Philadelphia Venture Report Highlights 2024 Growth

Despite challenging national trends, Greater Philadelphia’s startups raised $3.3 billion across 444 deals in 2024, a 37.5% increase from 2023. Key sectors like life sciences, healthcare, and tech are driving growth and attracting significant investments.

Wistar Research Scientist Dr. Michela Perego Shares Why She Relocated from Northern Italy to Philadelphia

Read the Chamber’s latest “Discovery Starts with Me” talent attraction interview with The Wistar Institute’s research scientist Dr. Michela Perego, where she discusses why she relocated from Northern Italy to Philadelphia for its life science opportunities and quality of life offerings.

Philadelphia’s Proscia Secures $50M to Advance AI-Driven Pathology Platform

Digital pathology software startup Proscia recently raised $50 million in new funding, bringing its total to $130 million. The investment will go toward enhancing its AI-powered pathology platform for accelerating precision medicine drug discovery.

Delaware Commits $30M Grant to Merck to Build New Facility in First State

Delaware’s State Investment Board gave the green light on a $30M grant to Merck, contingent on the company’s decision to set up operations at the Chestnut Run Innovation & Science Park outside of Wilmington.

Philadelphia to Host PGA TOUR Signature Event, Truist Championship, in May 2025

Philadelphia will host the PGA TOUR’s Truist Championship next month, bringing more than 70 of the PGA TOUR’s top golfers and about 15,000 spectators to the region. The event will highlight Greater Philadelphia’s status as a premier destination for world-class events and its ability to attract and host high-caliber tournaments and sporting events, including the FIFA World Cup in 2026.

Colliers Life Science Report 2025: Greater Philadelphia Maintains #4 U.S. Life Sciences Market Rank

The newly released 2025 National Life Sciences Report by Colliers shows Greater Philadelphia maintained its ranking as the #4 U.S. life science market.

Iovance Biotherapeutics Shares Plan to Expand at Philadelphia Navy Yard, Creating Hundreds of New Jobs

Iovance Biotherapeutics is set to significantly boost employment in the Greater Philadelphia region as the company announced plans to add hundreds of new jobs at its cell therapy manufacturing site at the Philadelphia Navy Yard.